Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Access to Data and Biospecimens, 2014
    Diffusion Tensor-based Biomarker for Parkinson's Disease

    Objective/Rationale:             
    Magnetic resonance imaging (MRI) is a common tool used to diagnose or evaluate brain diseases such as Parkinson’s disease. Typically, MRI images are read by a...

  • Rapid Response Innovation Awards, 2014
    Inhibition of Striatal-Enriched Phosphatase (STEP) to Improve Parkinson-Related Cognitive Dysfunction

    Study Rationale:                   
    As the enzyme striatal-enriched phosphatase (STEP) may be abnormally elevated in aged parkinsonian pre-clinical models with cognitive deficits, the possibility...

  • Therapeutic Pipeline Program, 2014
    Disease-modifying Chemical Probes to Inhibit Alpha-synuclein Aggregation

    Objective/Rationale:             
    There is a great need to discover novel therapeutic targets and strategies that halt or reverse the progression of Parkinson’s disease (PD). In this study we hope to...

  • Repositioning Drugs for PD, 2014
    DPP-4 Inhibitors for the Treatment of Parkinson’s Disease (Supplement)

    Promising Outcomes of Original Grant:
    Dipeptidyl protease-4 (DPP-4) inhibitors are widely used in the effective treatment of type 2 diabetes to safely regulate blood glucose levels. DPP-4 is the key...

  • Research Grant, 2014
    Chemical Modulator of Chaperone-mediated Autophagy in Parkinson's Disease

    Objective/Rationale:
    Brain cells depend on very efficient surveillance systems to identify defective components and break them apart to avoid accumulation and toxicity. We have found that in the brain...

  • Rapid Response Innovation Awards, 2014
    Impact of the Medical Food ErgoD2® on Alpha-synuclein and Iron Levels

    Objective/Rationale:             
    Although the causes of Parkinson’s disease (PD) are yet unknown, the overall health of the body likely plays a major role in disease initiation and progression...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.